3-(4-methoxy-anilino)-5-(2-methoxy-benzylthio)-1,2,4-triazole | 334539-52-5

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 3-(4-methoxy-anilino)-5-(2-methoxy-benzylthio)-1,2,4-triazole
• 英文别名: N-(4-methoxyphenyl)-3-[(2-methoxyphenyl)methylsulfanyl]-1H-1,2,4-triazol-5-amine
• CAS: 334539-52-5
• 化学式: C₁₇H₁₈N₄O₂S
• 分子量: 342.422
• InChiKey: GNKKFOKAICLWIY-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.1
• 重原子数：
  24
• 可旋转键数：
  7
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.18
• 拓扑面积：
  97.4
• 氢给体数：
  2
• 氢受体数：
  6

反应信息

• 作为产物：
  描述：

  4-甲氧基苯基 异硫氰酸酯 在 sodium hydroxide 、 potassium carbonate 、 溶剂黄146 、 三乙胺 、 肼 作用下， 以 乙醇 、 N,N-二甲基甲酰胺 、 乙腈 为溶剂， 反应 15.5h， 生成 3-(4-methoxy-anilino)-5-(2-methoxy-benzylthio)-1,2,4-triazole
  参考文献：
  名称：

  Highly Potent Inhibitors of Methionine Aminopeptidase-2 Based on a 1,2,4-Triazole Pharmacophore

  摘要：

  High-throughput screening for inhibitors of the human metalloprotease, methionine aminopeptidase-2 (MetAP2), identified a potent class of 3-anilino-5-benzylthio-1,2,4-triazole compounds. Efficient array and interative synthesis of triazoles led to rapid SAR development around the aniline, benzylthio, and triazole moeities. Evaluation of these analogs in a human MetAP2 enzyme assay led to the identification of several inhibitors with potencies in the 50-100 picomolar range. The deleterious effects on inhibitor potency by methylation of the anilino-triazole nitrogens, as well as the X-ray crystal structure of triazole 102 bound in the active site of MetAP2, confirm the key interactions between the triazole nitrogens, the active site cobalt atoms, and the His-231 side-chain. The structure has also provided a rationale for interpreting SAR within the triazole series. Key aniline (2-isopropylphenyl) and sulfur substituents (furanylmethyl) identified in the SAR studies led to the identification of potent inhibitors (103 and 104) of endothelial cell proliferation. Triazoles 103 and 104 also exhibited dose-dependent activity in an aortic ring tissue model of angiogenesis highlighting the potential utility of MetAP2 inhibitors as anticancer agents.

  DOI：

  10.1021/jm061182w

文献信息

• 1,2,4-triazole derivatives, compositions, process of making and methods of use
  申请人：Marino P. Joseph

  公开号：US20050267185A1

  公开（公告）日：2005-12-01

  Compounds of this invention are non-peptide, reversible inhibitors of type 2 methionine aminopeptidase, useful in treating conditions mediated by angiogenesis, such as cancer, haemangioma, proliferative retinopathy, rheumatoid arthritis, atherosclerotic neovascularization, psoriasis, ocular neovascularization and obesity.

  本发明的化合物是非肽类、可逆抑制剂，用于治疗通过血管生成介导的疾病，如癌症、血管瘤、增生性视网膜病变、类风湿性关节炎、动脉粥样硬化新生血管形成、牛皮癣、眼部新生血管形成和肥胖症。
• US7304082B2
  申请人：——

  公开号：US7304082B2

  公开（公告）日：2007-12-04
• Highly Potent Inhibitors of Methionine Aminopeptidase-2 Based on a 1,2,4-Triazole Pharmacophore
  作者：Joseph P. Marino,、Paul W. Fisher、Glenn A. Hofmann、Robert B. Kirkpatrick、Cheryl A. Janson、Randall K. Johnson、Chun Ma、Michael Mattern、Thomas D. Meek、M. Dominic Ryan、Christina Schulz、Ward W. Smith、David G. Tew、Thaddeus A. Tomazek、Daniel F. Veber、Wenfang C. Xiong、Yuuichi Yamamoto、Keizo Yamashita、Guang Yang、Scott K. Thompson

  DOI：10.1021/jm061182w

  日期：2007.8.1

  High-throughput screening for inhibitors of the human metalloprotease, methionine aminopeptidase-2 (MetAP2), identified a potent class of 3-anilino-5-benzylthio-1,2,4-triazole compounds. Efficient array and interative synthesis of triazoles led to rapid SAR development around the aniline, benzylthio, and triazole moeities. Evaluation of these analogs in a human MetAP2 enzyme assay led to the identification of several inhibitors with potencies in the 50-100 picomolar range. The deleterious effects on inhibitor potency by methylation of the anilino-triazole nitrogens, as well as the X-ray crystal structure of triazole 102 bound in the active site of MetAP2, confirm the key interactions between the triazole nitrogens, the active site cobalt atoms, and the His-231 side-chain. The structure has also provided a rationale for interpreting SAR within the triazole series. Key aniline (2-isopropylphenyl) and sulfur substituents (furanylmethyl) identified in the SAR studies led to the identification of potent inhibitors (103 and 104) of endothelial cell proliferation. Triazoles 103 and 104 also exhibited dose-dependent activity in an aortic ring tissue model of angiogenesis highlighting the potential utility of MetAP2 inhibitors as anticancer agents.